TIMOTHY TYSON - 16 Sep 2022 Form 3 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role
Director
Signature
/s/ Todd Rosenthal, as attorney-in-fact
Issuer symbol
SYRS
Transactions as of
16 Sep 2022
Net transactions value
$0
Form type
3
Filing time
19 Sep 2022, 17:06:52 UTC
Previous filing
29 Aug 2022
Next filing
03 Oct 2022

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24: Power of Attorney